We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This is HM Revenue and Customs' initial equality impact assessment.
The ‘tampon tax’ has been abolished - with a zero rate of VAT applying to women’s sanitary products coming into effect today (1 January 2021).
Final round of the £11.25 million Tampon Tax Fund announced
Ovarian Cancer Action, Beat, and Women in Prison among those receiving grants over £1m.
A European review has begun into the safety of radium-223 dichloride following an observed increase in the incidence of deaths and fractures in patients with chemotherapy-naive metastatic castration-resistant prostate cancer receiving radium-223 dichloride in combination with abiraterone acetate (Zytiga) and...
Period product company scooped the title for its novel menstruation product, the Tampliner.
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by Kosei Pharma, CST Pharma and Ordinant Medical Solutions from Italy and they have been re-labelled in Kosei...
DFID-funded Amacongo, run by Christian Aid, provides HIV and AIDS widows and orphans with essential aid
Employment Appeal Tribunal judgment of Mr Justice Singh on 13 December 2013.
Increased risk of stroke in older women should be taken into account in prescribing decisions.
Letters were sent about Buccolam (midazolam), misoprostol vaginal delivery system (Mysodelle), noradrenaline, Relenza (zanamivir), mycophenolate mofetil/mycophenolic acid, Flolan, and Fludara.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).